Rifaximin Therapy in Chronic Kidney Disease

NCT02342639 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

Jason Stubbs, MD